TOP
Nav Bar
  1. General Info
  2. Source Info
  3. Effects Info
  4. Reference
Phytochemical Details
01. General Information
Name Wilforlide A
PubChem CID 158477
Molecular Weight 454.7g/mol
Synonyms

wilforlide A

Formula C₃₀H₄₆O₃
SMILES CC1(C2CCC3(C(C2(CCC1O)C)CC=C4C3(CCC5(C4CC6(CC5OC6=O)C)C)C)C)C
InChI 1S/C30H46O3/c1-25(2)20-10-13-30(7)21(28(20,5)12-11-22(25)31)9-8-18-19-16-26(3)17-23(33-24(26)32)27(19,4)14-15-29(18,30)6/h8,19-23,31H,9-17H2,1-7H3/t19-,20-,21+,22-,23-,26-,27+,28-,29+,30+/m0/s1
InChIKey HHQJBWYXBWOFJY-YLXTXNMFSA-N
CAS Number 84104-71-2
ChEMBL ID CHEMBL484424
Structure 2D-img
Download
2D MOL 3D MOL
02. Source Information of Phytochemical
Tripterygium wilfordii Cool
Chineses Pinyin LeiGongTeng
Use Part Root, Leaf, Flower
Habitat HuNan, JiangXi, ZheJiang, FuJian, GuangDong, GuiZhou, YunNan, HaiNan, XiZang, TaiWan, ChongQing
Flavor Pungent, Bitter
Meridian Tropism Heart, Liver
Species
>Kingdom: Viridiplantae
 -->Phylum: Streptophyta
  -->Class: Equisetopsida
   -->Order: Celastrales
    -->Family: Celastraceae
     -->Genus: Tripterygium
      -->Species: Tripterygium wilfordii
03. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Drug(s) whose efficacy can be enhanced by this phytochemical
Hide/Show
Combination Pair ID: 265
Pair Name Wilforlide A, Docetaxel
Partner Name Docetaxel
Disease Info [ICD-11: 2C82] Prostate cancer Investigative
Gene Regulation Down-regulation Expression ABCB1 hsa5243
Down-regulation Expression CDKN1A hsa1026
In Vitro Model PC-3 Prostate carcinoma Homo sapiens (Human) CVCL_0035
DU145 Prostate carcinoma Homo sapiens (Human) CVCL_0105
In Vivo Model These PC3-TxR cells were suspended in a 1:1 mixture of Matrigel and RPMI 1640 and subcutaneously implanted into planks of mice via injection.
Result Wilforlide A was found to enhance the chemosensitizing effect of docetaxel both in vitro and in vivo. Further studies are warranted to verify wilforlide A as a new drug candidate to overcome docetaxel resistance in prostate cancer.
04. Reference
No. Title Href
1 Chemosensitizing Effect and Efficacy of Wilforlide A in Combination With Docetaxel in Drug-resistant Prostate Cancer. In Vivo. 2022 Sep-Oct;36(5):2020-2031. doi: 10.21873/invivo.12928. Click
It has been 46326 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP